Dwivedi, Krit http://orcid.org/0000-0003-4949-4550
Sharkey, Michael
Alabed, Samer
Langlotz, Curtis P.
Swift, Andy J.
Bluethgen, Christian
Funding for this research was provided by:
Wellcome Trust (222930/Z/21/Z, 4ward North 203914/Z/16 for Krit Dwivedi (K.D.). Andrew Swift AJS 205188/Z/16/Z)
Article History
Received: 28 April 2023
Revised: 25 June 2023
Accepted: 24 July 2023
First Online: 29 September 2023
Declarations
:
: The scientific guarantor of this publication is Andrew J. Swift.
: The authors of this manuscript declare relationships with the following companies:Conflicts of interest disclosures are as follows. None are directly related to this submitted work but have been extensively detailed for full disclosure.K. Dwivedi reports funding from Janssen Pharmaceuticals, outside the submitted work, and funding from the National Institute of Health Research UK.A. Swift reports honoraria and consultancy fees from Janssen Pharmaceuticals and received a research grant from GlaxoSmithKline. Christian Bluethgen reports support from the Kurt and Senta Herrmann Foundation and the Swiss Society of Radiology.M.Sharkey and S. Alabed have received funding from the National Institute of Health Research UK.Curtis Langlotz reports personal financial interests:Board of directors and shareholder, Bunkerhill Health.Option holder, whiterabbit.ai.Advisor and option holder, GalileoCDS.Advisor and option holder, Sirona Medical.Advisor and option holder, Adra.Advisor and option holder, Kheiron.Advisor, Sixth Street.Recent grant and gift support paid to institution:BunkerHill Health; Carestream; CARPL; Clarity; GE Healthcare; Google Cloud; IBM; IDEXX; Hospital Israelita Albert Einstein; Kheiron; Lambda; Lunit; Microsoft; Nightingale Open Science; Nines; Philips; Siemens Healthineers; Subtle Medical; VinBrain; Whiterabbit.ai; Lowenstein Foundation; Gordon and Betty Moore Foundation; Paustenbach Fund
: Multiple authors have significant statistical expertise. No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained. Ethical approval was granted by the Institutional Review Board at both centres and approved by the UK National Research Ethics Service (16/YH/0352).
: There may be subject overlap at the patient level with previously published works, as there have been multiple publications that have used the registry data that this study is based upon, the ASPIRE (Assessing the Severity of Pulmonary Hypertension In a Pulmonary Hypertension REferral Centre) registry.
: • prospective• experimental• multicentre study